PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers workflow navigation services; automated sample preparation kits; IntelliPlex platform that is designed for pCode technology with throughput sample-to-answer multiplexing assays; oncology assays, a portfolio for advanced molecular testing; and pCode coupling buffer sets. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does PlexBio Co., Ltd. (6572) operate in?
PlexBio Co., Ltd. belongs to the Other sector and operates in the Medical Devices industry.
What is PlexBio Co., Ltd. (6572) current stock price?
As of the latest data, PlexBio Co., Ltd. stock price is NT$7.81, with a previous close of NT$7.81.
What is PlexBio Co., Ltd. (6572) current market capitalization?
PlexBio Co., Ltd. market cap is approximately 809.50 million.
What is PlexBio Co., Ltd. (6572) Earnings Per Share (EPS)?
The trailing EPS is -NT$0.60.
Does PlexBio Co., Ltd. (6572) pay dividends?
No. PlexBio Co., Ltd. does not pay a dividend.
What is PlexBio Co., Ltd. (6572) beta (volatility) score?
PlexBio Co., Ltd. has a beta of 1.087, meaning its volatility is roughly in line with the market.